Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1

There is an urgent need to develop new life‐prolonging therapy for pancreatic ductal adenocarcinoma (PDAC). It is demonstrated that improved irinotecan delivery by a lipid bilayer coated mesoporous silica nanoparticle, also known as a silicasome, can improve PDAC survival through a chemo‐immunothera...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Adv Sci (Weinh)
Huvudupphovsmän: Liu, Xiangsheng, Jiang, Jinhong, Liao, Yu‐Pei, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Lin, Matthew, Wang, Xiang, Ji, Ying, Mei, Kuo‐Ching, Liu, Qi, Chang, Chong Hyun, Wainberg, Zev A., Nel, Andre E., Meng, Huan
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2021
Ämnen:
Full Papers
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7967046/
https://ncbi.nlm.nih.gov/pubmed/33747719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002147
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk